Ceva Sante Animale

Ceva Sante Animale, a French pharmaceutical preparation manufacturer, reported approximately 279.9 million kg CO2e in total carbon emissions for 2023. This includes Scope 1 and 2 emissions of about 61.8 million kg CO2e and Scope 3 emissions of approximately 218.4 million kg CO2e. A significant portion of their Scope 3 emissions, about 114.0 million kg CO2e, was attributed to purchased goods and services.

In 2022, the company's total carbon emissions were around 250.7 million kg CO2e, comprising approximately 55.7 million kg CO2e from Scope 1 and 2, and about 194.9 million kg CO2e from Scope 3. Purchased goods and services contributed approximately 113.1 million kg CO2e to their Scope 3 emissions in that year.

For 2021, Ceva Sante Animale reported Scope 1 and 2 emissions of approximately 53.4 million kg CO2e. No Scope 3 emissions data was disclosed for 2021.

Ceva Sante Animale has not publicly disclosed specific carbon reduction targets or commitments, such as those validated by the Science Based Targets initiative (SBTi) or participation in other climate initiatives.